B. BRAUN MEDICAL LIMITED
Get an alert when B. BRAUN MEDICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-02-14 (in 9mo)
Last made up 2026-01-31
Watchouts
Cash
£153K
+2% vs 2023
Net assets
£52M
+2.3% vs 2023
Employees
811
+6.4% vs 2023
Profit before tax
£10M
+37.9% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Name history
Renamed 3 times since incorporation
- B. BRAUN MEDICAL LIMITED 1998-05-29 → present
- AESCULAP LIMITED 1991-01-01 → 1998-05-29
- AESCULAP-SKIDMORE HOLDINGS LIMITED 1989-02-15 → 1991-01-01
- WF 156 LIMITED 1988-09-14 → 1989-02-15
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £228,427,000 | £257,842,000 | |
| Operating profit | £7,289,000 | £10,292,000 | |
| Profit before tax | £7,461,000 | £10,288,000 | |
| Net profit | £5,434,000 | £6,334,000 | |
| Cash | £150,000 | £153,000 | |
| Total assets less current liabilities | £61,548,000 | £61,792,000 | |
| Net assets | £50,443,000 | £51,608,000 | |
| Equity | £50,443,000 | £51,608,000 | |
| Average employees | 762 | 811 | |
| Wages | £35,758,000 | £40,575,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 3.2% | 4.0% | |
| Net margin | 2.4% | 2.5% | |
| Return on capital employed | 11.8% | 16.7% | |
| Gearing (liabilities / total assets) | 57.3% | 62.6% | |
| Current ratio | 1.61x | 1.39x | |
| Interest cover | 16.49x | 6.28x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Rödl & Partner Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared forecasts of profit and cash flow which indicate that the company will continue to generate cash inflows and remain profitable in future years. The directors therefore believe that preparing the financial statements on the going concern basis is appropriate.”
Group structure
- B. BRAUN MEDICAL LIMITED · parent
- B. Braun Sterilog Limited 100%
- Downs Surgical Limited 100%
- Aesculap Academia Company Limited 100%
- B. Braun Healthcare Limited 73.5%
- B. Braun Sterilog (Yorkshire) Limited 100%
- B. Braun Sterilog (Birmingham) Limited 100%
Significant events
- “The company acquired the trade and assets of the product business belonging to its sister company B. Braun Avitum UK Limited on 1 July 2024 for cash. The business sells renal and acute products and provides home haemodialysis.”
- “During the year B. Braun Medical Limited entered a Receivables Purchase Agreement with Landesbank Hessen-Thüringen Girozentrale arranged by B. Braun SE AG who also act as a guarantor. Any transfer of receivables under this agreement constitutes a true sale of receivables, and not a security arrangement for any obligations of the seller. At the year end the reduction in trade debtors was £26,034,000 without recourse to the seller.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 26 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CANNINGS, Craig Robert | Director | 2024-05-01 | Apr 1983 | British |
| JANDT, Christiane | Director | 2026-04-21 | Mar 1979 | German |
| KUEBLER, Roman | Director | 2024-01-11 | Nov 1979 | German |
Show 26 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HEWSON, Jeremy Peter Taylor | Secretary | — | 1997-12-31 |
| WATTERS, Gordon | Secretary | 1998-01-02 | 2010-12-08 |
| BAILEY-SMITH, Denis Peter | Director | 1998-04-01 | 2000-07-17 |
| BELLER, Annette, Frau Doctor | Director | 2012-04-02 | 2017-02-20 |
| CASH, Andrew John, Sir | Director | 2018-10-01 | 2024-05-23 |
| DARLING, Deborah Jane | Director | 2000-07-01 | 2016-04-15 |
| GLIDDON, Paul Ernest | Director | — | 1998-04-01 |
| GOLD, Donna Marie | Director | 2020-07-01 | 2024-05-01 |
| GROSSE, Heinz Walter, Dr | Director | 2005-04-11 | 2012-04-02 |
| HUX, Hans | Director | 1993-04-05 | 2020-01-31 |
| KNAEBEL, Hanns-Peter, Professor Doctor | Director | 2016-12-07 | 2017-04-11 |
| MARGREE, Anthony Laurence | Director | — | 1996-04-08 |
| MATTHEWS, Richard Philip | Director | 2013-01-01 | 2015-09-01 |
| MICHELFELDER, Claus, Dr | Director | — | 1998-08-19 |
| MITCHELL, Peter John | Director | — | 2015-09-01 |
| NIEMANN, Harald | Director | 1998-04-01 | 2005-03-14 |
| OATES, David | Director | 2001-05-01 | 2023-04-30 |
| PARDEN, Michael Francis | Director | 2023-05-01 | 2026-04-21 |
| PARDEN, Michael Francis | Director | 2013-01-01 | 2013-01-01 |
| PARFANIUK, Peter | Director | 1998-04-01 | 2017-04-30 |
| SCHULZ, Joachim, Dr | Director | 1992-01-02 | 1994-10-01 |
| SKELTON, Paul Henry | Director | 2010-01-04 | 2024-04-30 |
| STEEL, Paul Joseph | Director | 1994-06-01 | 2021-04-30 |
| THORPE, David William James | Director | 2000-11-10 | 2008-06-20 |
| UNGETHUM, Michael, Professor | Director | 1998-04-01 | 2016-12-07 |
| WATTERS, Gordon | Director | — | 2002-03-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mrs Barbara Braun-Ludicke | Individual | Voting 25–50% | 2016-04-06 | Ceased 2026-03-06 |
| Prof. Dr. Ludwig Georg Braun | Individual | Voting 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 209 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-28 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-28 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-12 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-02-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-07 | AA | accounts | Accounts with accounts type full | |
| 2025-02-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-23 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-14 | AA | accounts | Accounts with accounts type full | |
| 2024-05-01 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-12 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-17 | AA | accounts | Accounts with accounts type full | |
| 2023-05-02 | CH01 | officers | Change person director company with change date | |
| 2023-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-02 | TM01 | officers | Termination director company with name termination date | |
| 2023-04-12 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-02-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-08 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+12.9%
£228,427,000 £257,842,000
-
Cash
+2%
£150,000 £153,000
-
Net assets
+2.3%
£50,443,000 £51,608,000
-
Employees
+6.4%
762 811
-
Operating profit
+41.2%
£7,289,000 £10,292,000
-
Profit before tax
+37.9%
£7,461,000 £10,288,000
-
Wages
+13.5%
£35,758,000 £40,575,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers